Neurogene to Participate in Upcoming Conferences
Neurogene (NASDAQ: NGNE), a clinical-stage company focused on developing genetic medicines for rare neurological diseases, has announced its participation in three upcoming healthcare conferences in March.
The company will participate in:
- The TD Cowen 45th Annual Health Care Conference on March 3 at 9:50 a.m. ET
- The Leerink Global Healthcare Conference on March 10 at 1:00 p.m. ET
- The Stifel Virtual CNS Forum on March 19 at 9:30 a.m. ET
Management will engage in fireside chats at all three events, with additional investor meetings scheduled for the TD Cowen and Leerink conferences. Live webcasts of the fireside chats will be available through Neurogene's website's Investor Relations section, with replays available for a time.
Neurogene (NASDAQ: NGNE), un'azienda in fase clinica focalizzata nello sviluppo di medicinali genetici per malattie neurologiche rare, ha annunciato la sua partecipazione a tre conferenze sanitarie in programma a marzo.
L'azienda parteciperà a:
- La 45ª Conferenza Annuale sulla Salute di TD Cowen il 3 marzo alle 9:50 ET
- La Conferenza Globale sulla Salute di Leerink il 10 marzo alle 13:00 ET
- Il Forum Virtuale CNS di Stifel il 19 marzo alle 9:30 ET
La direzione parteciperà a discussioni informali in tutte e tre le manifestazioni, con ulteriori incontri con gli investitori programmati per le conferenze di TD Cowen e Leerink. Le trasmissioni in diretta delle discussioni informali saranno disponibili nella sezione Relazioni con gli Investitori del sito web di Neurogene, con repliche disponibili per un certo periodo.
Neurogene (NASDAQ: NGNE), una empresa en etapa clínica enfocada en desarrollar medicamentos genéticos para enfermedades neurológicas raras, ha anunciado su participación en tres próximas conferencias de salud en marzo.
La empresa participará en:
- La 45ª Conferencia Anual de Atención Médica de TD Cowen el 3 de marzo a las 9:50 a.m. ET
- La Conferencia Global de Salud de Leerink el 10 de marzo a la 1:00 p.m. ET
- El Foro Virtual CNS de Stifel el 19 de marzo a las 9:30 a.m. ET
La dirección participará en charlas informales en los tres eventos, con reuniones adicionales con inversores programadas para las conferencias de TD Cowen y Leerink. Las transmisiones en vivo de las charlas informales estarán disponibles a través de la sección de Relaciones con Inversores del sitio web de Neurogene, con repeticiones disponibles por un tiempo.
뉴로진(네덜란드: NGNE), 희귀 신경 질환을 위한 유전자 치료제를 개발하는 임상 단계의 회사가 3월에 예정된 세 개의 의료 회의에 참여한다고 발표했습니다.
회사는 다음 회의에 참여할 예정입니다:
- TD Cowen 제45회 연례 의료 회의가 3월 3일 오전 9시 50분 ET에 개최됩니다.
- 리어링크 글로벌 헬스케어 회의가 3월 10일 오후 1시 ET에 개최됩니다.
- 스티펠 가상 CNS 포럼이 3월 19일 오전 9시 30분 ET에 개최됩니다.
경영진은 세 가지 이벤트 모두에서 대화형 세션에 참여하며, TD Cowen 및 리어링크 회의에서는 추가 투자자 회의가 예정되어 있습니다. 대화형 세션의 실시간 웹캐스트는 뉴로진 웹사이트의 투자자 관계 섹션을 통해 제공되며, 일정 기간 동안 재방송이 가능합니다.
Neurogene (NASDAQ: NGNE), une entreprise en phase clinique axée sur le développement de médicaments génétiques pour les maladies neurologiques rares, a annoncé sa participation à trois conférences de santé à venir en mars.
L'entreprise participera à :
- La 45e Conférence Annuelle de Soins de Santé de TD Cowen le 3 mars à 9h50 ET
- La Conférence Mondiale de Soins de Santé de Leerink le 10 mars à 13h00 ET
- Le Forum Virtuel CNS de Stifel le 19 mars à 9h30 ET
La direction participera à des discussions informelles lors des trois événements, avec des réunions supplémentaires avec les investisseurs prévues pour les conférences de TD Cowen et de Leerink. Les webcasts en direct des discussions informelles seront disponibles dans la section Relations Investisseurs du site Web de Neurogene, avec des rediffusions disponibles pendant un certain temps.
Neurogene (NASDAQ: NGNE), ein klinisches Unternehmen, das sich auf die Entwicklung genetischer Medikamente für seltene neurologische Erkrankungen konzentriert, hat seine Teilnahme an drei bevorstehenden Gesundheitskonferenzen im März bekannt gegeben.
Das Unternehmen wird an folgenden Konferenzen teilnehmen:
- Der 45. jährlichen Gesundheitskonferenz von TD Cowen am 3. März um 9:50 Uhr ET
- Der Leerink Global Healthcare Conference am 10. März um 13:00 Uhr ET
- Dem Stifel Virtual CNS Forum am 19. März um 9:30 Uhr ET
Das Management wird an allen drei Veranstaltungen an informellen Gesprächen teilnehmen, wobei zusätzliche Investorenmeetings für die Konferenzen von TD Cowen und Leerink geplant sind. Live-Webcasts der informellen Gespräche werden im Bereich Investor Relations der Website von Neurogene verfügbar sein, mit Wiederholungen für eine bestimmte Zeit.
- None.
- None.
TD Cowen 45th Annual Health Care Conference
Format: Management will participate in a fireside chat and investor meetings
Date: Monday, March 3 at 9:50 a.m. ET
Leerink Global Healthcare Conference
Format: Management will participate in a fireside chat and investor meetings
Date: Monday, March 10 at 1:00 p.m. ET
Stifel Virtual CNS Forum
Format: Management will participate in a fireside chat
Date: Wednesday, March 19 at 9:30 a.m. ET
Live webcasts of the fireside chats will be accessible from the Investor Relations section of Neurogene’s website under events, where a replay of the events will also be available for a limited time.
About Neurogene
The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders. This includes selecting a delivery approach to maximize distribution to target tissues and designing products to maximize potency and purity for an optimized efficacy and safety profile. The Company’s novel and proprietary EXACT transgene regulation platform technology allows for the delivery of therapeutic levels while limiting transgene toxicity associated with conventional gene therapy. Neurogene has constructed a state-of-the-art gene therapy manufacturing facility in
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224253404/en/
Company Contact:
Cara Mayfield
Vice President, Corporate Affairs
cara.mayfield@neurogene.com
Investor Contact:
Melissa Forst
Argot Partners
Neurogene@argotpartners.com
Source: Neurogene Inc.
FAQ
What conferences will Neurogene (NGNE) attend in March 2024?
How can investors access Neurogene's (NGNE) conference presentations?
What type of presentations will Neurogene (NGNE) give at these healthcare conferences?
What is the schedule for Neurogene's (NGNE) March 2024 conference presentations?
